CS Algorithm
CS Algorithm
Evaluation and treatment of infants (<30 days old) exposed to syphilis in utero*
Start INFANTS AND BIRTHING PARENT (e.g., mother) SHOULD HAVE SERUM RPR OR VDRL TITER DRAWN AT DELIVERY
• CS findings on physical exam • Not treated • Adequately treated with benzathine penicillin
No to all No to all
• Infant titer ≥4 fold higher than mother’s titer • Inadequately treated§ G appropriate for stage, initiated ≥30 days
• + darkfield or PCR of placenta, cord lesion, • Treatment undocumented before delivery
or body fluid • Treated with a non-benzathine penicillin G regimen AND
• + silver stain of placenta or cord • Initiated treatment <30 days before delivery • No concern for reinfection or treatment failure
* Scenario 4 – in which an infant at delivery has a normal physical exam and titer < 4-fold mother’s titer, AND the mother was adequately treated prior to becoming pregnant and sustains RPR titers <1:4 or
VDRL<1:2 throughout pregnancy – is not included.
† CSF test results obtained during the neonatal period can be difficult to interpret; normal values differ by gestational age and are higher in preterm infants.
‡ Alternative: Procaine penicillin G 50,000 units/kg/dose IM in a single daily dose for 10 days.
§ Benzathine Penicillin G (BPG or Bicillin-LA), administered according to stage of disease and initiated at least 30 days prior to delivery is the only adequate treatment for syphilis during pregnancy.
II Evaluation is not necessary if a 10-day course of parenteral therapy is administered, although such evaluations might be useful. If the neonate’s nontreponemal test is nonreactive and the mother’s risk for
untreated syphilis is low, a single IM dose of BPG can be considered without evaluation.
¶ All neonates with reactive nontreponemal tests should receive careful follow-up examinations and serologic testing (i.e., a nontreponemal test) every 2–3 months until the test becomes nonreactive. Neonates with
a negative nontreponemal test at birth whose mothers were seroreactive at delivery should be retested at 3 months to rule out serologically negative incubating congenital syphilis at the time of birth.
FOR MORE INFORMATION ABOUT SCENARIO 4 MANAGEMENT, TREATMENT OF SYPHILIS IN PREGNANCY, NEONATAL CSF INTERPRETATION, AND CS INFANT FOLLOW-UP, PLEASE REFER TO
THE CDC 2021 STI TREATMENT GUIDELINES. Revised 2/2022